Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature.

Notably, despite a clear trend there is heterogeneity between expression of individual genes even at the extreme ends of cisplatin sensitivity and resistance.

also in 9,436 other papers